23444-full
jhartless
Sex: F
Data Quality: 1 star
MS: 18 yrs
Type: Secondary Progressive
Sensation: Moderate
Overall: Mild
Cognition: mild
Vision: mild
Speech: mild
Swallowing: mild
Upper limb: mild
Walking: moderate
jhartless
Female, 53 years
Soddy Daisy, TN
Primary Condition
MS
Type
Secondary Progressive
First symptom
Diagnosis
See more

Treatment charts require Flash. If you have problems installing Flash, visit the FAQ for help.

Get Adobe Flash player

jhartless's Ampyra is for:

jhartless's side effects of Ampyra:

jhartless's Ampyra History (Ongoing)
Ampyra (dalfampridine (4-ap extended release))
20 mg Daily Jun 10, 2010 - Last Update
Evaluations
Date Dosage Walking problems Perceived effectiveness Unsteady gait Perceived effectiveness Side Effects Adherence Burden
Jul 12, 2010 20 mg Daily ? ? ModerateModerateModerateModerate AlwaysAlwaysAlwaysAlways Not at allNot at allNot at allNot at all
Date
Jul 12, 2010
Advice & Tips
I had high hopes, but unfortunately so far I haven't been able to see any change at all in unsteady gait or walking speed.
Cost
$100-199 monthly

About Ampyra (Prescription Drug)

Ampyra™ is the brand name for dalfampridine, an extended release formulation of 4-aminopyridine or 4-AP. Ampyra, a potassium channel blocker, is indicated as a treatment to improve walking in patients with multiple sclerosis.

Learn more about Ampyra in our Ampyra Community Report.

Back to jhartless's Profile